PDZK1IP1

Across TCGA pan-cancer cohorts, PDZK1IP1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated PDZK1IP1 data layer compared with 21 for mass-spec protein and 8 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher PDZK1IP1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated PDZK1IP1 expression acts as an unfavorable survival marker.

LUAD and STAD are the cancer types where PDZK1IP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.141	0.812	<.001	24	view →
STAD	OS	Median	All	0.187	0.688	.008	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

PDZK1IP1–LUAD (OS)

Open the LUAD breakdown →